#AACE2021: Top 20-Hyperlipidemia in Young Patients with Type 1 Diabetes: Review of Current Guidelines and Evidence

Hyperlipidemia in Young Patients with Type 1 Diabetes: Review of Current Guidelines and Evidence

Video Transcription

Video Summary

In this video, Dr. Dennis Brumer discusses the role of dyslipidemia in young patients with type 1 diabetes. He reviews the current guidelines and evidence supporting early management of dyslipidemia in this population. Dr. Brumer emphasizes the importance of comprehensive management of cardiovascular risk factors, including glycemic control, blood pressure reduction, and lipid management. He highlights the increased cardiovascular risk and mortality in patients with type 1 diabetes and the need for early intervention. Dr. Brumer also discusses the importance of LDL cholesterol in predicting cardiovascular outcomes in type 1 diabetes. He presents data from various studies and trials, including the DCCT trial, the Swedish National Diabetes Register, and the Heart Protection Study, demonstrating the benefits of statin therapy in reducing cardiovascular events in patients with type 1 diabetes. Dr. Brumer concludes by summarizing the current treatment guidelines, recommending moderate to high-intensity statin therapy in patients with type 1 diabetes.

Asset Subtitle

Dennis Bruemmer, MD, PhD | Daniel L. Hurley, MD, FACE

Keywords

dyslipidemia

type 1 diabetes

early management

cardiovascular risk factors

glycemic control

LDL cholesterol

statin therapy

cardiovascular events

treatment guidelines